![](https://investorshub.advfn.com/uicon/211216.png?cb=1569258534)
Thursday, June 29, 2023 3:04:18 PM
Hattrick3
16m
@Dirtymartini66 as frustrating as it’s been, this is far from over. No solutions are available, the Covid Therapeutic revenue projections are well over $30 billion in a few short years. Piles of money to be made. Start connecting the dots, the “sister” company Pharma Ther has just signed an agreement with Virtruvias Therapeutics out of Alabama. They have a CEO who has been in the business for decades and their Director worked for Johnson and Johnson for decades. They are also experts in the generic space. Phrrf is down the hall from Revive and they own a large chunk of Revive shares, enough to pay for their Ketarx trial when it launches if Revive can do something with Buci. Way too much money to be made and a drug that by every measurement has worked in every study that’s been done to date; trial data is coming. Is it possible that it doesn’t go any further; yep! Just not probable with the $$$ on the table for the company that has a Covid therapeutic; the drug works.
Bullish
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM